ORCHIDPHAR

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company, at their meeting held on May 27, 2010 have recommended a dividend of Re.10/- per share on the equity share of Rs.10/- each.

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the consolidated Results for the year ended on 31-MAR-2010 as follows: Net Sales of Rs. 129872.31 lacs for year ending on 31-MAR-2010 against Rs. 126002.49 lacs for the year ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 33925.38 lacs for the year ending on 31-MAR-2010 against Rs. (4898.99) lacs for the year ending on 31-MAR-2009.

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2010 as follows: Net Sales of Rs. 120518.59 lacs for year ending on 31-MAR-2010 against Rs. 115676.96 lacs for the year ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 33133.96 lacs for the year ending on 31-MAR-2010 against Rs. (5217.47) lacs for the year ending on 31-MAR-2009.

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange that Industrial Development Bank of India has withdrawn the nomination of Shri. S Jeyakumar and instead appointed Shri. T. A Ganesh, Deputy General Manager, Industrial Development Bank of India Limited, Mumbai as its nominee on the Board of the Company with effect from May 10, 2010.

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange that the company will be publishing the audited financial results for the year ended March 31, 2010 within a period of 60 days, i.e., on or before May 30, 2010.

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 05, 2010, titled "Orchid enters into an out-licensing and distribution alliance with Alvogen to market oral non-antibiotic formulations in the US".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 29, 2010, titled "Orchid settles Litigation with Forest Laboratories for Memantine Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ORCHID_pr_29042010.ZIP target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange that Mr. S Krishnan, Head-Finance & Business Planning has been inducted into the Board of Orchid as Executive Director with effect from April 28, 2010. The appointment has been approved by the Board at its Meeting held on April 28, 2010.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that "Dr. C. Bhaktavatsala Rao, who has been associated with Orchid from the inception as a member of the Board and subsequently appointed as Deputy Managing Director has resigned from the services of the Company on March 29, 2010. He has been relieved from the Board / services of Orchid".

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a press release dated March 30, 2010 titled "Orchid completes Business Transfer transaction with Hospira, Inc". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchidchemicals_pr_31032010.ZIP target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding disclosure in terms of SEBI (Substantial Acquisition of Shares and takeovers) Regulations, 1997. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/orchid_reg_26032010.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding disclosure in terms of SEBI (Substantial Acquisition of Shares and takeovers) Regulations, 1997. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/orchid_reg_19032010.ZIP target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has submitted to the Exchange a copy of the proceedings of the Postal Ballot Process of the Company held on December 15, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchipharma_PPB_09022010.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the shareholders of the Company have approved with requisite majority, the Ordinary Resolution for transfer and sale of the generic injectable formulations business of the Company, circulated by means of Postal Ballot. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). <a href=/content/corporate/Orchidchemi_RPB_01022010.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a media release dated January 29, 2010, titled "Orchid registers turnover of Rs 332 crore during Q3 FY10". A copy of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ORCHID_pr_29012010.ZIP target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a media release dated January 08, 2010, titled "Orchid receives Tentative US FDA nod for Memantine Tablets". A copy of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_mediarelease_08012010.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has submitted to the Exchange a copy of the Notice of Voting through Postal Ballot Pursuant to Section 192A of the Companies Act, 1956.A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ORCHIDCHEM_NPB_04012010.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the Company has purchased USD 19.778 million aggregate face value of Bonds. The Company is in the process of extinguishing such Bonds.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that "The Company is exploring opportunities for the buy-back of outstanding FCCBs issued by the Company pursuant to, and in compliance with, RBI regulations. The Company may purchase the bonds from the markets and extinguish from time to time at its sole discretion, under the regulations".

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the Board at its meeting held on December 15, 2009, has approved the sale and transfer of its generic injectables pharmaceuticals business to Hospira, Inc., USA. The acquisition by Hospira includes Orchid's beta-lactam antibiotics manufacturing complex (comprising cephalosporin, penicillin and carbapenem facilities) and pharmaceutical research and development (R&D) facility at Irungattukottai (Chennai), India as well as its generic injectable product portfolio and pipeline. Hospira would have access to the talented bases of

Orchid Chemicals & Pharmaceuticals Ltd has submitted to the Exchange the Forms as received by the company from M/s. Adurjee & Bros. Private Limited. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/orchid_adurjee_23112009.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a press release dated October 30, 2009 titled "Orchid registers revenue of Rs 314 crore during Q2 FY10". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_PR_30102009.ZIP target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the standalone Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 61066.48 lacs for half year ending on 30-SEP-2009 against Rs. 62169.14 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. (4296.22) lacs for the half year ending on 30-SEP-2009 against Rs. (7230.64) lacs for the half year ending on 30-SEP-2008.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 30484.59 lacs for quarter ending on 30-SEP-2009 against Rs. 33914.02 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. (1320.17) lacs for the quarter ending on 30-SEP-2009 against Rs. (4066.03) lacs for the quarter ending on 30-SEP-2008.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a press release dated October 19, 2009, titled "Orchid awarded the Corporate Social Responsibility Award 2008-09 by Government of Tamilnadu". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_PR_20102009.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has submitted to the Exchange a copy of the Proceedings of the Annual General Meeting of the Company held on September 30, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_AGMProc_15102009.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has submitted to the Exchange a copy of the press release issued by the company, regarding an updated note on Piperacillin Tazobactam product in the US. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/orchid_pr_25092009.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has submitted to the Exchange a press release regarding an Information note on Piperacillin Tazobactam. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/orchid_PR_24092009.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has submitted to the Exchange a copy of the Notice of the Annual General Meeting of the members of the company to be held on September 30, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/orchidchem_AGMNot_18092009.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a media release dated September 18, 2009, titled "Orchid receives final US FDA nod for Zaleplon Capsules". A copy of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/orchid_MR_18092009.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a media release dated September 16, 2009, titled "Orchid's Piperacillin - Tazobactam ANDAs receive US FDA nod Granted 180-days generic drug exclusivity". A copy of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/orchid_MRel_16092009.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the Annual General Meeting of the Company has been proposed to be held on September 30, 2009. Further, the dates for closure of Register of Members for the purpose of Annual General Meeting and for payment of dividend has been fixed by the Board from September 19, 2009 to September 30, 2009 (both days inclusive).

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a media release dated August 13, 2009, titled "Orchid receives Final US FDA nod for Sumatriptan Tablets". A copy of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_MR_13082009.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a media release dated August 12, 2009, titled "Orchid Chemicals & Pharmaceuticals Ltd (Orchid) and Schering-Plough Corporation (SGP) Settle Clarinex� and Clarinex� RediTabs� Patent Lawsuits". A copy of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_MR_12082009.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the press release dated July 31, 2009 titled "Orchid registers turnover of Rs 309 crore during Q1 FY10". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_PR_31072009.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 30581.89 lacs for quarter ending on 30-JUN-2009 against Rs. 28765.92 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. (2976.05) lacs for the quarter ending on 30-JUN-2009 against Rs. (3164.6) lacs for the quarter ending on 30-JUN-2008.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the press release dated July 03, 2009 titled "Orchid receives US FDA approval for Amlodipine Besylate Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/orchid_PR_03072009.ZIP target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the press release dated June 29, 2009, titled " Orchid registers a turnover of Rs. 1211 crore during FY09". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/orchid_pressrel_29062009.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the Board of Directors of the Company at its meeting held on June 29, 2009 has recommended a dividend of Re. 1/- per share on the equity share of Rs.10/- each.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 115676.96 lacs for year ending on 31-MAR-2009 against Rs. 123891.62 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. (5217.47) lacs for the year ending on 31-MAR-2009 against Rs. 18453.61 lacs for the year ending on 31-MAR-2008.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the consolidated Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 126002.49 lacs for year ending on 31-MAR-2009 against Rs. 130096.39 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. (4898.99) lacs for the year ending on 31-MAR-2009 against Rs. 17533.99 lacs for the year ending on 31-MAR-2008.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange with reference to a news item appearing in a website attributing to the Company an announcement that the Company (Orchid) has received US FDA approval for its generic product Imipenem-Cilastatin 250 mg Injection. The Company has clarified that Orchid had made no such announcement and states that its ANDAs for the said injection in applicable dosage forms and strengths are under review by the US FDA.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a media release dated May 11, 2009 titled "Orchid receives Tentative US FDA nod for Sumatriptan Tablets". A copy of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ORCHIDCHEM_MR_11052009.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that : "The company will be publishing the audited financial results for the year ended March 31, 2009 within a period of 3 months, i.e., on or before June 30, 2009".

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the Company has so far purchased USD 37.8 million aggregate face value of 2012 bonds (US$ Zero Coupon Convertible Bonds due 2012) and USD 2.25 million aggregate face value of 2010 bonds (US$ Zero Coupon Convertible Bonds due on 2010) and the said bonds have been extinguished.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a press release dated April 09, 2009, titled "Orchid's facility conferred global recognition". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/OrchidChem_PR_09042009.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that "Mr. L Chandrasekar, Company Secretary and Compliance Officer has resigned, and relieved from the services of the Company with effect from the closing hours of March 31, 2009. Mrs. Bhoomijha Murali, General Manager - Legal & Secretarial has taken over as the Company Secretary from April 1, 2009. Mrs. Bhoomijha Murali, who has been designated as General Manager - Legal and Company Secretary, will also be the Compliance Officer of the Company".

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the Company has purchased USD 12.1 million aggregate face value of Bonds. The Company is in the process of extinguishing such Bonds. Further, the Company may also purchase from the markets and extinguish additional Bonds from time to time at its sole discretion.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the Company has purchased USD 25.7 million aggregate face value of Bonds and is in the process of extinguishing such Bonds. Further, the Company may also purchase from the markets and extinguish additional Bonds from time to time at its sole discretion.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the result of postal ballot conducted for the following matters: 1) Increase in Borrowing Limits, 2) Creation of Mortgages and Charges on the Company's properties against increased borrowing limits. The ordinary resolutions Nos.1 and 2, as set out in the notice dated January 28, 2009 were passed by the shareholders of the Company with requisite majority. The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corp